 - Subjects must have completed 2-6 cycles of a standard systemic therapy, with or without radiation therapy, consisting of at least 2 anti-tumor agents as first-line treatment for Stage IIIIV disease, and have documented complete response CR, partial response PR, or stable disease SD per Response Evaluation Criteria in Solid Tumors RECIST. 